Business Description
GoodRx Holdings Inc
NAICS : 923120
SIC : 5045
ISIN : US38246G1085
Share Class Description:
GDRX: Ordinary Shares - Class ADescription
GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.95 | |||||
| Equity-to-Asset | 0.48 | |||||
| Debt-to-Equity | 0.93 | |||||
| Debt-to-EBITDA | 6.53 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 1.63 | |||||
| Beneish M-Score | -2.62 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -3 | |||||
| 3-Year EPS without NRI Growth Rate | 73.5 | |||||
| 3-Year FCF Growth Rate | -16.7 | |||||
| 3-Year Book Growth Rate | 2.1 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 21.2 | |||||
| Future 3-5Y Total Revenue Growth Rate | 6 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 26.48 | |||||
| 9-Day RSI | 35.81 | |||||
| 14-Day RSI | 41.24 | |||||
| 6-1 Month Momentum % | 24.95 | |||||
| 12-1 Month Momentum % | 19.34 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 7.12 | |||||
| Quick Ratio | 7.12 | |||||
| Cash Ratio | 5.49 | |||||
| Days Sales Outstanding | 60.49 | |||||
| Days Payable | 115.68 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.2 | |||||
| Shareholder Yield % | 3.67 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 91.08 | |||||
| Operating Margin % | -3.6 | |||||
| Net Margin % | -1.18 | |||||
| FCF Margin % | 11 | |||||
| ROE % | -1.06 | |||||
| ROA % | -0.54 | |||||
| ROIC % | -0.51 | |||||
| ROC (Joel Greenblatt) % | 0.87 | |||||
| ROCE % | 0.07 | |||||
| Years of Profitability over Past 10-Year | 2 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 19.17 | |||||
| PE Ratio without NRI | 108.33 | |||||
| PS Ratio | 3.57 | |||||
| PB Ratio | 3.37 | |||||
| Price-to-Tangible-Book | 13.27 | |||||
| Price-to-Free-Cash-Flow | 32.6 | |||||
| Price-to-Operating-Cash-Flow | 19.45 | |||||
| EV-to-EBIT | 2264.8 | |||||
| EV-to-Forward-EBIT | 13.33 | |||||
| EV-to-EBITDA | 24.06 | |||||
| EV-to-Forward-EBITDA | 6.89 | |||||
| EV-to-Revenue | 3.49 | |||||
| EV-to-Forward-Revenue | 3.27 | |||||
| EV-to-FCF | 31.72 | |||||
| Price-to-Graham-Number | 7.93 | |||||
| Price-to-Net-Current-Asset-Value | 54.17 | |||||
| Earnings Yield (Greenblatt) % | 0.04 | |||||
| FCF Yield % | 3.21 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:GDRX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return %
Total Annual Return %
GoodRx Holdings Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 750.265 | ||
| EPS (TTM) ($) | -0.02 | ||
| Beta | 1.86 | ||
| Volatility % | 94.22 | ||
| 14-Day RSI | 41.24 | ||
| 14-Day ATR ($) | 0.34241 | ||
| 20-Day SMA ($) | 6.8255 | ||
| 12-1 Month Momentum % | 19.34 | ||
| 52-Week Range ($) | 4.135 - 9.37 | ||
| Shares Outstanding (Mil) | 395 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
GoodRx Holdings Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
GoodRx Holdings Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
GoodRx Holdings Inc Frequently Asked Questions
What is GoodRx Holdings Inc(GDRX)'s stock price today?
The current price of GDRX is $6.50. The 52 week high of GDRX is $9.37 and 52 week low is $4.14.
When is next earnings date of GoodRx Holdings Inc(GDRX)?
The next earnings date of GoodRx Holdings Inc(GDRX) is 2024-05-09.
Does GoodRx Holdings Inc(GDRX) pay dividends? If so, how much?
GoodRx Holdings Inc(GDRX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers